SCHEMBL1775683

SCHEMBL1775683

CCOC(=O)c1cc(C=C2CCN(C(=O)OC(C)(C)C)CC2)n(C)n1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 1/20 0.43
GPR119 Q8TDV5 2/20 0.42
GRM5 P41594 4/20 0.40
HPGD P15428 2/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
TP53 P04637 1/20 0.38
POLB P06746 1/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
ATM Q13315 1/20 0.37
CYP3A4 P08684 2/20 0.36
CYP1A2 P05177 1/20 0.36
ACKR3 P25106 1/20 0.35
ESR2 Q92731 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1777935 0.86 GRM5 (0.41) ADORA1GPR119GRM5HPGDKDM4E
SCHEMBL1776136 0.79 FAAH (0.38) LMNAGAAKMT2ASMN1; SMN2CYP1A2
SCHEMBL25195438 0.78 ATM (0.48) HPGDALDH1A1KDM4ETP53POLB
SCHEMBL4033844 0.75 ATM (0.48) ADORA1GPR119GRM5ALDH1A1MEN1
SCHEMBL31751639 0.74 ADORA1 (0.43) ADORA1GPR119GRM5HPGDALDH1A1
SCHEMBL19329569 0.73 TP53 (0.42) ADORA1GPR119GRM5HPGDALDH1A1
SCHEMBL15300178 0.71 CYP1A2 (0.44) KDM4EPOLBLMNAGAAKMT2A
SCHEMBL24401161 0.71 ADORA1 (0.44) ADORA1GPR119GRM5HPGDALDH1A1
SCHEMBL803581 0.71 ADORA1 (0.48) ADORA1GPR119GRM5KDM4ESMN1; SMN2
SCHEMBL27166556 0.71 LMNA (0.51) KDM4EMEN1LMNAGAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943636-B2 1-substituted pyrazolo (3,4-C) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases 3M INNOVATIVE PROPERTIES COMPANY (US) 2011-05-17 US disclosed
US-20090163533-A1 1-Substituted Pyrazolo (3,4-C) Ring Compounds as Modulators of Cytokine Biosynthesis for the Treatment of Viral Infections and Neoplastic Diseases COLEY PHARMACEUTICAL GROUP, INC. (US) 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163533-A1 1-Substituted Pyrazolo (3,4-C) Ring Compounds as Modulators of Cytokine Biosynthesis for the Treatment of Viral Infections and Neoplastic Diseases IL2, IL4, IFNG ADORA1 2558/4885GPR119 2732/4885GRM5 3108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.